CAS 182284-68-0: Lirioprolioside B

Lirioprolioside B is a glycoside, which is a specialized type of organic compound formed by the condensation of sugar moieties with other functional groups. It is isolated from the plant genus Liriope, specifically known for its traditional use in herbal medicine. This compound's mode of action is primarily attributed to its interaction with cellular metabolic pathways, which may include antioxidant properties or modulation of enzyme activities. Researchers are particularly interested in Lirioprolioside B due to its potential pharmacological applications. Studies have suggested its utility in ameliorating oxidative stress, which is important in the pathophysiology of various chronic diseases. Additionally, it may exhibit immunomodulatory effects, enhancing the body's defense mechanisms against pathogens. Extraction and synthesis research continues to explore its full range of biological activities and therapeutic potentials, aiming to understand underlying mechanisms and efficacy in preclinical models.

Lirioprolioside B is a steroidal glycoside isolated from the underground organs of Liriope spicata var. prolifera.